Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax? ; volume:23 ; number:1 ; day:17 ; month:1 ; year:2019 ; pages:1-2 ; date:12.2019
Critical care ; 23, Heft 1 (17.1.2019), 1-2, 12.2019
- Creator
-
Honore, Patrick M.
Bels, David De
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
Spapen, Herbert D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-019-2311-2
- URN
-
urn:nbn:de:101:1-2019021822364911382877
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Bels, David De
- Kugener, Luc
- Redant, Sebastien
- Attou, Rachid
- Gallerani, Andrea
- Spapen, Herbert D.
- SpringerLink (Online service)
Other Objects (12)
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Attainment of therapeutic vancomycin level within the first 24 h
The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Attainment of therapeutic vancomycin level within the first 24 h
The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Attainment of therapeutic vancomycin level within the first 24 h
The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?